Guide for patients & caregivers

TI-RADS 4 Thyroid Nodule: What Does It Mean and What Happens Next?

A TI-RADS 4 thyroid nodule explained: what the TR4 score means, the ACR size cut-offs for FNA biopsy or follow-up scans, and questions to ask your clinician.

By SameCase EditorialUpdated 6 min read

Prepared with AI assistance and checked against the cited sources. No independent clinician review has been completed. How we prepare articles

What does a TI-RADS 4 thyroid nodule mean?

A TI-RADS 4 (TR4) thyroid nodule is one that scored 4 to 6 points on the American College of Radiology (ACR) ultrasound system, the second-highest of its five levels. Under ACR criteria, FNA biopsy is recommended if the nodule is 1.5 cm or larger, and follow-up ultrasound is recommended if it measures 1 to 1.4 cm.

Thyroid nodules are very common. The American Thyroid Association says about half of people have one by age 60, and Cleveland Clinic notes that more than 90% of nodules found in adults are benign. A TR4 score means the ultrasound showed some features that deserve a closer look. It does not confirm or rule out cancer.

This guide is for adults reading an existing thyroid ultrasound report. It explains the terms and the size thresholds so you can prepare questions. It cannot interpret your own scan or set your follow-up. If your nodule is TR3, the separate TI-RADS 3 guide covers that level.

Symptoms that need earlier care

Most thyroid nodules cause no symptoms. The NHS advises seeing a GP or your own clinician for a neck lump, a hoarse voice that is not getting better, difficulty swallowing that is not getting better, or pain or a pressing feeling in the front of the neck. Do not wait for a routine scan date if these appear or change.

The NHS advises asking for urgent help if you are having difficulty breathing. If breathing becomes severely difficult, use local emergency services. RadiologyInfo lists bleeding and infection as possible, though rare, risks of thyroid biopsy, so contact the team promptly about increasing neck swelling or signs of infection afterwards.

How does a nodule end up as TI-RADS 4?

ACR TI-RADS gives points for five ultrasound features: composition, echogenicity (how bright or dark the nodule looks), shape, margins and echogenic foci, which include some types of calcification. The points are added up. In the ACR reporting template, a total of 4 to 6 points is TR4, and 7 or more is TR5.

Different combinations can reach TR4. For example, the template gives 2 points for a solid nodule and 2 points for a hypoechoic (darker) one, so a solid, hypoechoic nodule with no other scored features totals 4. Other features, such as a taller-than-wide shape or punctate echogenic foci, carry 3 points each and can move a nodule into TR4 or higher.

RadiologyInfo notes that ultrasound cannot tell benign from cancerous lumps with complete certainty. That is why the score is paired with size: the score sets how closely to look, and the size decides whether a biopsy or a scan comes next. Some reports use a different scoring system with a similar name, so check that yours says ACR TI-RADS before comparing it with the thresholds below.

TI-RADS 4 size thresholds: FNA or follow-up?

The ACR thyroid ultrasound reporting template sets out these recommendations by category and maximum size. Your report should state the largest dimension in centimetres.

  • TR4, 1.5 cm or larger: ultrasound-guided fine-needle aspiration (FNA) biopsy is recommended.
  • TR4, 1 to 1.4 cm: follow-up ultrasound at 1, 2, 3 and 5 years.
  • TR4, under 1 cm: the ACR chart sets no FNA or follow-up threshold for this size.
  • For comparison, the thresholds are higher for TR3 (FNA from 2.5 cm) and lower for TR5 (FNA from 1 cm).
  • Significant growth, in the template's terms: an increase of 20% or more in two dimensions, with a minimum increase of 2 mm.

What happens at a TR4 follow-up scan?

At each follow-up ultrasound, the nodule is measured again and compared with earlier images. The ACR template asks the reporter to record whether the size has changed significantly, whether its features have changed, and whether its TI-RADS category has changed.

A nodule that stays the same usually continues on the agreed schedule. Significant growth, new features or a move to TR5 is a reason for your clinician to review the plan, which may include FNA. Keep copies of every report, especially if you change clinic, so each new scan can be compared with the last.

In an FNA, a thin needle collects cells from the nodule while ultrasound guides it. RadiologyInfo says it is usually done as an outpatient and is usually completed in less than 30 minutes, and the area may be sore for one to two days. Tell the team about any blood-thinning medicine, but do not stop or change a prescribed medicine unless the prescriber or biopsy team tells you to.

A pathologist examines the cells. The American Thyroid Association says a benign result is obtained in up to 80% of biopsies. Sometimes the sample does not contain enough cells and the biopsy needs repeating; the guide on non-diagnostic thyroid FNA explains that result. RadiologyInfo describes needle biopsy of the thyroid as close to 95% accurate when the sample is adequate.

What else affects the plan besides the score?

The ultrasound score is one part of the picture. The National Cancer Institute says blood tests to check thyroid hormone levels may be done when a nodule is found. The American Thyroid Association notes that a nuclear thyroid scan can help with the uncommon nodules that cause an overactive thyroid.

Personal history also matters. The National Cancer Institute lists age, sex and radiation exposure as factors that can affect thyroid cancer risk. Tell your clinician about past radiation to the head or neck, a family history of thyroid cancer, or any new symptoms, even if the report does not mention them. Your clinician may recommend a different plan from the chart for these reasons.

Questions to ask your clinician

Bring the full ultrasound report, not just the impression line, and any earlier scans. These questions can help you leave with a clear plan.

  • Does the report use ACR TI-RADS, and which features added up to my TR4 score?
  • What is the maximum size, and was it compared with an earlier scan?
  • Does my nodule fall into the FNA, follow-up or no-threshold group, and does anything in my history change that?
  • Have my thyroid blood tests been checked, and what did they show?
  • If I need follow-up scans, when is the next one, who books it, and what would bring it forward?
  • If FNA is advised, how will I get the result, and what happens if the sample is non-diagnostic?

How can similar cases help you prepare?

On SameCase, patients and verified doctors share de-identified cases. Reading how people with a TR4 nodule of a similar size were followed up can show which questions they asked and which details mattered, such as earlier scans, blood tests or growth between scans.

Other people's cases cannot tell you what your nodule is or what your plan should be. Use them to sharpen your questions, then take those questions to the clinician who has your full report and history.

Sources and further reading

For patients & caregivers

Share your case and learn from others

Learn from doctors and other people's cases to find a way forward with your health problem. New cases are public immediately. Don't add names or identifying details.

Keep learning